Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Daiichi Sankyo
Boehringer Ingelheim
HealthPartners Institute
Mayo Clinic
Tempus AI
Memorial Sloan Kettering Cancer Center
Apollomics Inc.
Elevation Oncology
Optimal Health Research
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Pfizer
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Northwestern University
Wake Forest University Health Sciences
Massachusetts General Hospital
Sun Yat-sen University
Tetra Bio-Pharma
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
Amgen
Bristol-Myers Squibb
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
InSightec
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
GE Healthcare
Pharmacyclics LLC.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Hoag Memorial Hospital Presbyterian